Molecular Study of Virulence Factors of Candida spp. That Isolated from Cancer Patients

Authors

  • Zahraa K. Taiban Department of Community Health, Kufa, Technical Institute, Al-Furat Al-Awsat Technical University 31001, Kufa, Al-Najaf, Iraq.
  • Suaad Kadium Department of Biology, Science, Kufa University, Kufa, Al-Najaf, Iraq.

DOI:

https://doi.org/10.36320/ajb/v16.i2.18013

Keywords:

Candida, Cancer, Multiplex- PCR technique, Virulence factors

Abstract

study of microbes and cancer is considered one of the challenges in sustainable development. Candida is an opportunistic pathogenic fungus, which is inclined to infect the host with faulty immune function involving patients with cancer. A growing many of research have shown that Candida infection rise the host's vulnerability to cancer such as colorectal, gastric, and oral cancer. Aim: This investigation demonstrates the isolation and identification of Candida spp. from cancer patients of Middle Euphrates Cancer Center in Al- Najaf governorate, Method: (51) blood specimens were collected for the preparation of serum.

      The serum is cultured on SDA media and the culture is examined for microbial growth, such as culture on SDA media, Chromo agar, microscopic examination, and then by Multiplex- PCR technique. Results: The current investigate showed infection percentage with opportunistic microorganisms was demonstrated as follows: C. tropicalis appeared in 40% in males and 0% in females , C. albicans appeared 10% in males, 5% in females, C. albicans appeared in cancer 10% in males, 5% in females, C. guilliermondii appeared in cancer 0% in males and 2% in females, C. parapsilosis and C. dubliniensis didn’t appear in cancer. In cancer isolates the ALS1 gene was found strongly in C. albicans, and don’t found in C. guillermondii, and weakly appeared in C. tropicalis, and the PLB1gene was found weakly in C. albicans, and don’t found in C. guillermondii, and C. tropicalis. Conclusion: In the normal state, the blood is sterile, but when the immunity is suppressed or weakened as a result of a specific symptom or disease, the whole body and the blood are also vulnerable to any opportunistic microbe that grows and multiplies with it. So the presence of microbes in the blood is a strong indicator of weak immunity in cancer patients to the point of penetration of Candida into the blood. We concluded from our current study that some pathogenic microbes can be isolated from the sera of cancer patients, as some types of Candida were isolated, which include C.albicans, C. tropicalis, ,and C.guillermondii.Our results of this study indicated the capacity of some of Candidia spp. to produced phospholipase enzyme. Not all C. albicans isolates was positive for phospholipase production, we also conclude that some genes of virulence factors don’t necessary to express and Candida can be pathogenic without it.

Downloads

Download data is not yet available.

References

1.Maaroufi Y., De Bruyne J.M., Duchateau V., Georgala A., Crokaert F. (2004).Early detection and identification of commonly encountered Candida species from simulated blood cultures by using a real-time PCR-based assay. J. Mol. Diagn. 6, 108-114.

2. Innings A., Ullberg M., Johansson A., Rubin C.J., Noreus N., Isaksson, Herrmann B. (2007). Multiplex real-time PCR targeting the RNase P RNA gene for detection and identification of Candida species in blood. J. Clin. Microbiol. 45, 874-880.

3.Casadevall, A.(2007). Determinants of virulence in the pathogenic fungi. Fungal Biol Rev. 21:130–132.

4.Pilmis, B.; Puel, A. and Lortholary, O. (2016). New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect;22(8):681-683.

5.Cole, D.C.; Govender, N.P. and Chakrabarti, A. (2017). Improvement of fungal disease identification and management: combined health systems and public health approaches. Lancet Infect Dis. 2017.

6.Romo, J.A. and Kumamoto, C.A.,(2020).On commensalism of Candida. Journal of Fungi, 6(1), p.16.

7. Pfaller, M.; Pappas, P.G. and Wingard, J.R. (2006). Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis. 42(4):1519-27.

8.Calderone, R.A., Fonzi, W.A., 2001. Virulence factors of Candida albicans. Trends Microbiology, 9, 327- 335.

9.Tarini, N.M.A., Wahid, M.H., Ibrahim, F., Yasmon, A., Djauzi, S., 2010. Development of multiplex-PCR assay for rapid detection of Candida spp. Medical Journal of Indonesia, 19, 83-87.

10. Ali, Y.K. (2022). Molecular study of fungal isolates associated withdiabetic foot ulcer patients in Al_Najaf province and evaluate inhibition activity of some natural products Faculty of Science/ University of Kufa.

11.Eldesouky, I., Mohamed, N., Khalaf, D., Salama, A., Elsify, A., Ombarak, R., El-Ballal, S., Effat, M., Shabrawy, M.A.L., 2016. Candida mastitis in dairy cattle with molecular detection of Candida albicans. Kafkas Universitesi Veteriner Fakültesi Dergisi, 22, 461-464.

12. Zahraa, M.W. (2016). Phenotypic and molecular characterization of Candida species isolated from hospital acquired infections in Hilla city. MSc. College of Science for Women/ University of Babylon.

13. Ali, Y.K. (2018). Genotypic characterization of fungal species isolated from patients with different cases in Al-najaf province. MSc, Faculty of Science/ University of Kufa.

14.Ataa, K.A. (2020). Detection of morphogenesis gene in C. albicans isolated from different clinical caces. MSc, Faculty of Science/ University of Kufa.

15.Deorukhkar, M. and Saini, S. (2014). “Virulence markers and antifungal susceptibility profile of Candida glabrata: an emerging pathogen,”British Microbiology Research Journal 4(1): 35–45.

16.Posteraro, B., M. Sanguinetti, L. Masucci, L. Romano, G. Morace, and G. Fadda. 2000. Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from Candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples. J. Clin. Microbiol. 38:1609–1614.

18.Domingues,F.M.; Grumach, A.S.; Duarte, A.J.and De-Moraes,V. D. (2009).Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer? Med Mycol.47:201-5.

19. Lim ,Y.; Rosli, R.; Seow, F. and Chong ,P.(2012). Candida and invasive candidiasis: back to basic. Eur .J. Clin .Microbiol. Infect . Dis. 31(1):21-31.

20.Hoyer,L.L. (2001). The ALS gene family of Candida albicans. Trends Microbiology, 9, 176-180.

21.Mousa, W., Elmonir, W., Abdeen 2016. Molecular typing, virulence genes and potential public health implications of Candida albicans isolated from bovine milk. Japanese Journal of Veterinary Kadry, A.A., El-Ganiny AM, El-Baz A.M., 2018. Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans. African Health Science, 18, 1166-1174.Research, 64, 211- 215.

22.Zarei Mahmoudabadi A, Zarrin M, Miry S. Phospholipase activity of Candida albicans isolated from vagina and urine samples. Jundishapur J Microbiol. 2010; 3(4): 169-73.

23.Mohandas, V. and Ballal, M. (2011).Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J. Glob. Infect Dis. 3(1): 4-8.

24.Kohler GA, Brenot A, Haas-Stapleton E, Agabian N, Deva R, Nigam S. Phospholipase A2 and phospholipase B activities in fungi. Biochim Biophys Acta 2006; 1761:1391–9.

Downloads

Published

2023-08-30

How to Cite

K. Taiban, Z., & Kadium, S. (2023). Molecular Study of Virulence Factors of Candida spp. That Isolated from Cancer Patients. Al-Kufa University Journal for Biology, 16(2), 103-110. https://doi.org/10.36320/ajb/v16.i2.18013

Share